For the first time, researchers have quantified the different mutational profiles of clusters of cells in individual tumors in patients with bowel cancer that has spread to other parts of the body. The research could have important consequences on the efficacy of therapies: in these 'mixed' tumors, some tumor cell clusters might be sensitive to a targeted therapy while others are resistant.

Source: Researchers quantify proportion of different genetic mutations in individual bowel cancers


David Cottle

UBB Owner & Administrator